financetom
Business
financetom
/
Business
/
BRIEF-Advent Strikes €4.1Bn Deal To Sell Generic Drugmaker Zentiva To GTCR - FT
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Advent Strikes €4.1Bn Deal To Sell Generic Drugmaker Zentiva To GTCR - FT
Sep 10, 2025 8:36 PM

Sept 10 (Reuters) -

* ADVENT STRIKES €4.1BN DEAL TO SELL GENERIC DRUGMAKER

ZENTIVA TO

GTCR - FT

Source text: https://tinyurl.com/3xxawd76

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Roku Expected to Benefit From Expanding Partnerships Following 'Solid' Q2 Results, Wedbush Says
Roku Expected to Benefit From Expanding Partnerships Following 'Solid' Q2 Results, Wedbush Says
Aug 1, 2025
10:53 AM EDT, 08/01/2025 (MT Newswires) -- Roku ( ROKU ) reported solid Q2 results, provided promising guidance and is expected to benefit from its expanding partnerships, growing ad inventory and better content recommendations on its platform, Wedbush analysts said in a note Friday. The company reported Q2 revenue of $1.11 billion, a 15% increase year-over-year, beating analyst consensus. Platform...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Novo Nordisk Receives FDA Approval for Alhemo to Prevent Bleeding in Hemophilia A, B Without Inhibitors
Novo Nordisk Receives FDA Approval for Alhemo to Prevent Bleeding in Hemophilia A, B Without Inhibitors
Aug 1, 2025
10:49 AM EDT, 08/01/2025 (MT Newswires) -- Novo Nordisk ( NVO ) said Thursday that the US Food and Drug Administration has approved Alhemo (concizumab-mtci) as a once-daily prophylaxis to prevent or reduce the frequency of bleeding in adults and children above 12 years with hemophilia A or B without inhibitors. The approval is based on the results of a...
Cigna Group Remains On Track With 'Stop-Loss Recovery,' Oppenheimer Says
Cigna Group Remains On Track With 'Stop-Loss Recovery,' Oppenheimer Says
Aug 1, 2025
10:47 AM EDT, 08/01/2025 (MT Newswires) -- Cigna Group ( CI ) remains on track with its stop-loss recovery and its business continues to avoid several broader managed care pressures, with minimal government exposure, Oppenheimer said in a note Thursday. The company aims to recover 100 basis points of margin between 2026 and 2027 through its stop-loss recovery strategy, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved